• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Man­u­fac­tur­ing roundup: Biono­va to ex­pand man­u­fac­tur­ing space; Es­ton­ian man­u­fac­tur­er gets €18M in­vest­ment

3 years ago
Manufacturing

SK Bio­science plans $261M ex­pan­sion in South Ko­rea with new fa­cil­i­ty

3 years ago
R&D
Manufacturing

Ther­mo Fish­er shrinks head­count in San Diego area, ax­ing over 200 po­si­tions

3 years ago
People
Pharma

Ex­clu­sive: Astel­las buys Su­per Bowl ad to dri­ve menopause symp­tom aware­ness

3 years ago
Pharma
Marketing

Lon­za breaks ground on $500M+ Swiss man­u­fac­tur­ing fa­cil­i­ty

3 years ago
Manufacturing

Up­dat­ed: Ab­b­Vie leaves some on­col­o­gy pro­grams out of 2023 pipeline high­lights

3 years ago
R&D
Pharma

Prokar­i­um rais­es $30M, push­es new bac­te­ria im­munother­a­py for blad­der can­cer to clin­ic

3 years ago
Financing

Non-opi­oid drug de­vel­op­er snags PhI­II funds; aTyr and Spruce line up cap­i­tal

3 years ago
Financing
News Briefing

UK mi­cro­cap faces par­tial clin­i­cal hold in mid-stage IPF tri­al

3 years ago
R&D
FDA+

The top 100 ven­ture in­vestors in bio­phar­ma to­day. Who's stay­ing at the deals ta­ble?

3 years ago
Deals
Bioregnum

As­traZeneca snips IL-12 can­di­date from pipeline as it sharp­ens I/O fo­cus

3 years ago
R&D

Ali­gos cuts an­oth­er 10% of its work­force in repri­or­i­ti­za­tion for NASH and Covid pipelines

3 years ago
People
R&D

PhI­II im­plo­sion forces Gala­pa­gos to scrap a fil­ing plan for fil­go­tinib

3 years ago
R&D
Pharma

Ma­gen­ta CEO ex­its, 84% of staff let go as shut­ter­ing looms

3 years ago
People

Ex­clu­sive: Ver­i­ly wel­comes Atara Bio­ther­a­peu­tics vet­er­an as new CFO

3 years ago
People
Pharma

Dex­com's spokescelebri­ty Nick Jonas re­turns to Su­per Bowl in new glu­cose mon­i­tor com­mer­cial

3 years ago
Pharma
Marketing

New Te­va CEO Richard Fran­cis repri­or­i­tizes to 'get back to growth'

3 years ago
Pharma

DC court over­rules PhRMA's bid to shut down drug im­ports from Cana­da

3 years ago
Pharma
Law

FDA com­mis­sion­er floats ideas on how to bet­ter han­dle the pan­dem­ic

3 years ago
FDA+

Sanofi re­news so­cial cam­paign to re­mind that vac­cines let peo­ple ‘Dream Big’

3 years ago
Pharma
Marketing

Up­dat­ed: Dai­ichi Sankyo to es­tab­lish Japan's first mR­NA vac­cine man­u­fac­tur­ing fa­cil­i­ty — re­port

3 years ago
Coronavirus
Manufacturing

Bay­er taps Roche's Bill An­der­son to lead phar­ma gi­ant as CEO

3 years ago
People
Pharma

As­traZeneca moves for­ward with a $360M API plant in Ire­land

3 years ago
Pharma
Manufacturing

Ovid brings two Big Phar­ma vets on board as new CMO, head of epilep­sy re­search

3 years ago
People
R&D
First page Previous page 389390391392393394395 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times